Detalhe da pesquisa
1.
Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls.
Am J Epidemiol
; 191(4): 724-734, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753175
2.
A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model.
BMC Infect Dis
; 21(1): 1244, 2021 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895161
3.
Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines.
BMC Med
; 14: 98, 2016 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27363534
4.
Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review.
Clin Microbiol Infect
; 30 Suppl 1: S4-S13, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007387
5.
A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
Clin Microbiol Infect
; 30 Suppl 1: S14-S25, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802750
6.
Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England.
Vaccine
; 38(47): 7558-7568, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32807531